Related references
Note: Only part of the references are listed.The pervasive presence of fluctuating oxygenation in tumors
Laura I. Cardenas-Navia et al.
CANCER RESEARCH (2008)
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Mark W. Dewhirst et al.
NATURE REVIEWS CANCER (2008)
Regulation of HIF-1α stability through S-nitrosylation
Fang Li et al.
MOLECULAR CELL (2007)
Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia:: Implications for anticancer therapies
Philippe Martinive et al.
CANCER RESEARCH (2006)
Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery
Philippe Martinive et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Hypoxia signalling in cancer and approaches to enforce tumour regression
Jacques Pouyssegur et al.
NATURE (2006)
Practicalities of drugging the phosphatidylinositol-3-kinase/Akt cell survival signaling pathway
Garth Powis et al.
CLINICAL CANCER RESEARCH (2006)
Mitochondria as signaling organelles in the vascular endothelium
M Quintero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor
J Lanzen et al.
CANCER RESEARCH (2006)
The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors
C Baudelet et al.
NMR IN BIOMEDICINE (2006)
Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1α in cancer:: Role of free radical formation
M Quintero et al.
CANCER RESEARCH (2006)
Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy
KG Brurberg et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
DH Kong et al.
CANCER RESEARCH (2005)
Signalling via the hypoxia-inducible factor-1 alpha requires multiple posttranslational mofications
C Brahimi-Horn et al.
CELLULAR SIGNALLING (2005)
PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1α from pVHL-independent degradation
J Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia?
C Baudelet et al.
PHYSICS IN MEDICINE AND BIOLOGY (2004)
Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications
B Gallez et al.
NMR IN BIOMEDICINE (2004)
Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis
P Sonveaux et al.
CIRCULATION RESEARCH (2004)
Physiological and pathological responses to hypoxia
C Michiels
AMERICAN JOURNAL OF PATHOLOGY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Oxygen sensing by HIF hydroxylases
CJ Schofield et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Redistribution of intracellular oxygen in hypoxia by nitric oxide:: Effect on HIF1α
T Hagen et al.
SCIENCE (2003)
Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases
E Metzen et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Temporal heterogeneity in oxygen tension in human melanoma xenografts
KG Brurberg et al.
BRITISH JOURNAL OF CANCER (2003)
How does blood oxygen level-dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors?
C Baudelet et al.
MAGNETIC RESONANCE IN MEDICINE (2002)
Harnessing the response to tissue hypoxia -: HIF-1α and therapeutic angiogenesis
KA Vincent et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins
A Brouet et al.
CIRCULATION RESEARCH (2001)
Transduction pathways involved in hypoxia-inducible FACTOR-1 phosphorylation and activation
E Minet et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells
A Brouet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
